{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:42:51Z","timestamp":1788460971709,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Brazilian National Research Council","award":["301465\/2017-7"],"award-info":[{"award-number":["301465\/2017-7"]}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.atherosclerosis.2018.12.002","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T17:54:35Z","timestamp":1544118875000},"page":"9-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Adverse interaction between HDL and the mass of myocardial infarction"],"prefix":"10.1016","volume":"281","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4716-9543","authenticated-orcid":false,"given":"Alexandre A.S.","family":"Soares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6465-356X","authenticated-orcid":false,"given":"Luiz Sergio F.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Bonilha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor W.","family":"Virginio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson","family":"Nadruz Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otavio Rizzi","family":"Coelho-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose C.","family":"Quinaglia e Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlando","family":"Petrucci Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7127-2052","authenticated-orcid":false,"given":"Andrei C.","family":"Sposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.atherosclerosis.2018.12.002_bib1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijcard.2011.04.012","article-title":"Gender differences in acute myocardial infarction, twenty-five years registration","volume":"160","author":"Coppieters","year":"2012","journal-title":"Int. J. Cardiol."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2018.12.002_bib2","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMra071667","article-title":"Myocardial reperfusion injury","volume":"357","author":"Yellon","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2018.12.002_bib3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/01.RES.0000054201.60308.1A","article-title":"High-density lipoproteins protect isolated rat hearts from ischemia-reperfusion injury by reducing cardiac tumor necrosis factor-alpha content and enhancing prostaglandin release","volume":"92","author":"Calabresi","year":"2003","journal-title":"Circ. Res."},{"issue":"13","key":"10.1016\/j.atherosclerosis.2018.12.002_bib4","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/CIRCULATIONAHA.105.607135","article-title":"High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia\/reperfusion injury in vivo via the S1P3 lysophospholipid receptor","volume":"114","author":"Theilmeier","year":"2006","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2018.12.002_bib5","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00125-003-1094-8","article-title":"Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study","volume":"46","author":"Soedamah-Muthu","year":"2003","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2018.12.002_bib6","first-page":"75","article-title":"High-density lipoproteins and myocardial necrosis in patients with acute myocardial infarction and ST segment elevation","volume":"213","author":"Fabregat-Andres","year":"2013","journal-title":"Rev. Clin. Esp."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2018.12.002_bib7","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.amjcard.2006.04.006","article-title":"Impact of low high-density lipoproteins on in-hospital events and one-year clinical outcomes in patients with non-ST-elevation myocardial infarction acute coronary syndrome treated with drug-eluting stent implantation","volume":"98","author":"Wolfram","year":"2006","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.12.002_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jjcc.2014.04.002","article-title":"Impact of low level of high-density lipoprotein-cholesterol sampled in overnight fasting state on the clinical outcomes in patients with acute myocardial infarction (difference between ST-segment and non-ST-segment-elevation myocardial infarction)","volume":"65","author":"Ji","year":"2015","journal-title":"J. Cardiol."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2018.12.002_bib9","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.amjcard.2013.05.050","article-title":"Relation of admission high-density lipoprotein cholesterol level and in-hospital mortality in patients with acute non-ST segment elevation myocardial infarction (from the National Cardiovascular Data Registry)","volume":"112","author":"Acharjee","year":"2013","journal-title":"Am. J. Cardiol."},{"issue":"20","key":"10.1016\/j.atherosclerosis.2018.12.002_bib10","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1093\/eurheartj\/ehn364","article-title":"Patterns and prognostic implications of low high-density lipoprotein levels in patients with non-ST-segment elevation acute coronary syndromes","volume":"29","author":"Roe","year":"2008","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2018.12.002_bib11","article-title":"Predictive and protective role of high-density lipoprotein cholesterol in acute myocardial infarction","author":"Park","year":"2018","journal-title":"Cardiol. J."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.12.002_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001412","article-title":"Relationship of high-density lipoprotein cholesterol with periprocedural myocardial injury following elective percutaneous coronary intervention in patients with low-density lipoprotein cholesterol below 70 mg\/dL","volume":"4","author":"Li","year":"2015","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2018.12.002_bib13","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/gt.2013.30","article-title":"Beneficial effects of selective HDL-raising gene transfer on survival, cardiac remodelling and cardiac function after myocardial infarction in mice","volume":"20","author":"Gordts","year":"2013","journal-title":"Gene Ther."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2018.12.002_bib14","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1172\/JCI42946","article-title":"Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease","volume":"121","author":"Besler","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2018.12.002_bib15","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jacl.2016.08.003","article-title":"HDL function is impaired in acute myocardial infarction independent of plasma HDL cholesterol levels","volume":"10","author":"Annema","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2018.12.002_bib16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cca.2017.12.031","article-title":"HDL acceptor capacities for cholesterol efflux from macrophages and lipid transfer are both acutely reduced after myocardial infarction","volume":"478","author":"Soares","year":"2018","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2018.12.002_bib17","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.atherosclerosis.2014.10.103","article-title":"HDL levels and oxidizability during myocardial infarction are associated with reduced endothelial-mediated vasodilation and nitric oxide bioavailability","volume":"237","author":"Carvalho","year":"2014","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2018.12.002_bib18","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/ATVBAHA.110.218685","article-title":"Timing and dose of statin therapy define its impact on inflammatory and endothelial responses during myocardial infarction","volume":"31","author":"Sposito","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2018.12.002_bib19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0002-9149(67)90023-9","article-title":"Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients","volume":"20","author":"Killip","year":"1967","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2018.12.002_bib20","first-page":"678","article-title":"Peri-infarct zone characterized by cardiac magnetic resonance imaging is directly associated with the inflammatory activity during acute phase myocardial infarction","volume":"37","author":"Quinaglia e Silva","year":"2014","journal-title":"Inflammation"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2018.12.002_bib21","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s00330-004-2387-0","article-title":"Assessment of ventricular function and mass by cardiac magnetic resonance imaging","volume":"14","author":"Alfakih","year":"2004","journal-title":"Eur. Radiol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2018.12.002_bib22","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0735-1097(02)01712-6","article-title":"Gender differences and normal left ventricular anatomy in an adult population free of hypertension. A cardiovascular magnetic resonance study of the Framingham Heart Study Offspring cohort","volume":"39","author":"Salton","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2018.12.002_bib23","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.jacc.2004.09.020","article-title":"Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model","volume":"44","author":"Amado","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2018.12.002_bib24","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0022-2275(20)35376-1","article-title":"A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum","volume":"22","author":"Chapman","year":"1981","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2018.12.002_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119664","article-title":"Improving reconstituted HDL composition for efficient post-ischemic reduction of ischemia reperfusion injury","volume":"10","author":"Brulhart-Meynet","year":"2015","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2018.12.002_bib26","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1161\/01.CIR.60.4.805","article-title":"The influence of location and extent of myocardial infarction on long-term ventricular dysrhythmia and mortality","volume":"60","author":"Geltman","year":"1979","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2018.12.002_bib27","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/clc.22663","article-title":"The contemporary value of peak creatine kinase-MB after ST-segment elevation myocardial infarction above other clinical and angiographic characteristics in predicting infarct size, left ventricular ejection fraction, and mortality","volume":"40","author":"Hartman","year":"2017","journal-title":"Clin. Cardiol."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2018.12.002_bib28","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s10554-017-1131-1","article-title":"Predictors of left ventricular remodeling after ST-elevation myocardial infarction","volume":"33","author":"Hendriks","year":"2017","journal-title":"Int. J. Cardiovasc. Imag."},{"issue":"20","key":"10.1016\/j.atherosclerosis.2018.12.002_bib29","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1093\/eurheartj\/ehl094","article-title":"Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD-2 trial","volume":"27","author":"Kloner","year":"2006","journal-title":"Eur. Heart J."},{"issue":"411","key":"10.1016\/j.atherosclerosis.2018.12.002_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam6084","article-title":"High-density lipoprotein delivered after myocardial infarction increases cardiac glucose uptake and function in mice","volume":"9","author":"Heywood","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2018.12.002_bib31","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12944-017-0429-2","article-title":"HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium","volume":"16","author":"Ruiz","year":"2017","journal-title":"Lipids Health Dis."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2018.12.002_bib32","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/CIRCULATIONAHA.112.108753","article-title":"Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling","volume":"127","author":"Riwanto","year":"2013","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2018.12.002_bib33","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1365-2362.2010.02345.x","article-title":"Intravenous clusterin administration reduces myocardial infarct size in rats","volume":"40","author":"Van Dijk","year":"2010","journal-title":"Eur. J. Clin. Invest."},{"issue":"24","key":"10.1016\/j.atherosclerosis.2018.12.002_bib34","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1161\/CIRCULATIONAHA.116.025687","article-title":"Safety and tolerability of CSL112, a reconstituted, infusible, plasma-derived apolipoprotein A-I, after acute myocardial infarction: the AEGIS-I trial (ApoA-I event reducing in ischemic syndromes I)","volume":"134","author":"Michael Gibson","year":"2016","journal-title":"Circulation"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018315211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018315211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T19:50:21Z","timestamp":1662580221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915018315211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":34,"alternative-id":["S0021915018315211"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.12.002","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse interaction between HDL and the mass of myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}